Enzyme producer announces technical director

Bio-Cat, the enzyme producer, announced that Dr. Thomas Laaman has joined the company as the new technical director. "Dr. Laaman brings a very customer focused approach to enzyme product development and considers innovation to be the key for success", said Ed Schuler, CEO and founder of Bio-Cat.

Laaman said, "we have to translate needs that customers express to us into tangible commercial products but we need to also go way beyond that.  We need to be willing to creatively extrapolate our unique Bio-Cat enzymes into market segments and applications where the researchers in those applications could not have anticipated a unique enzyme solution to long existing or newly developing challenges."

Prior to joining Bio-Cat, Laaman led research and product development at Merck, FMC, and Pepsico as well as the Norwegian company Pronova and the Japanese company Kimica.  He combines the highest level of basic and applied scientific knowledge obtained from earning degrees at Cornell, Ohio State, Texas A&M, and a post-doctoral stint at the University of Texas Medical School. 

According to Laaman, "behind every big problem or challenge there often lies an equally big enzyme opportunity.  Bio-Cat has a 25 year history of success and innovation doing things that much bigger companies weren't able or willing to do and we intend to build on that great foundation and existing corporate culture to reach even higher heights. The key will be using Bio-Cat enzymes and microbials to help bring our many loyal and newly acquired customers the success they crave."